rs61753093

Variant summary

Our verdict is Benign. The variant received -17 ACMG points: 0P and 17B. BP4_StrongBP6_Very_StrongBP7BS2

The NM_152743.4(BRAT1):​c.2208G>T​(p.Leu736Leu) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00255 in 1,613,090 control chromosomes in the GnomAD database, including 14 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★). Synonymous variant affecting the same amino acid position (i.e. L736L) has been classified as Likely benign.

Frequency

Genomes: 𝑓 0.0018 ( 1 hom., cov: 34)
Exomes 𝑓: 0.0026 ( 13 hom. )

Consequence

BRAT1
NM_152743.4 synonymous

Scores

2

Clinical Significance

Benign/Likely benign criteria provided, multiple submitters, no conflicts B:8

Conservation

PhyloP100: -0.431
Variant links:
Genes affected
BRAT1 (HGNC:21701): (BRCA1 associated ATM activator 1) The protein encoded by this ubiquitously expressed gene interacts with the tumor suppressing BRCA1 (breast cancer 1) protein and and the ATM (ataxia telangiectasia mutated) protein. ATM is thought to be a master controller of cell cycle checkpoint signalling pathways that are required for cellular responses to DNA damage such as double-strand breaks that are induced by ionizing radiation and complexes with BRCA1 in the multi-protein complex BASC (BRAC1-associated genome surveillance complex). The protein encoded by this gene is thought to play a role in the DNA damage pathway regulated by BRCA1 and ATM. [provided by RefSeq, Mar 2012]

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -17 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.8).
BP6
Variant 7-2538327-C-A is Benign according to our data. Variant chr7-2538327-C-A is described in ClinVar as [Likely_benign]. Clinvar id is 472963.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BP7
Synonymous conserved (PhyloP=-0.431 with no splicing effect.
BS2
High Homozygotes in GnomAdExome4 at 13 AR gene

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
BRAT1NM_152743.4 linkc.2208G>T p.Leu736Leu synonymous_variant Exon 14 of 14 ENST00000340611.9 NP_689956.2 Q6PJG6-1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
BRAT1ENST00000340611.9 linkc.2208G>T p.Leu736Leu synonymous_variant Exon 14 of 14 1 NM_152743.4 ENSP00000339637.4 Q6PJG6-1

Frequencies

GnomAD3 genomes
AF:
0.00184
AC:
280
AN:
152216
Hom.:
1
Cov.:
34
show subpopulations
Gnomad AFR
AF:
0.000314
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00196
Gnomad ASJ
AF:
0.00461
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00930
Gnomad FIN
AF:
0.0000941
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.00245
Gnomad OTH
AF:
0.00383
GnomAD2 exomes
AF:
0.00259
AC:
644
AN:
248466
AF XY:
0.00287
show subpopulations
Gnomad AFR exome
AF:
0.000312
Gnomad AMR exome
AF:
0.00148
Gnomad ASJ exome
AF:
0.00569
Gnomad EAS exome
AF:
0.0000553
Gnomad FIN exome
AF:
0.000372
Gnomad NFE exome
AF:
0.00281
Gnomad OTH exome
AF:
0.00180
GnomAD4 exome
AF:
0.00262
AC:
3826
AN:
1460756
Hom.:
13
Cov.:
66
AF XY:
0.00273
AC XY:
1986
AN XY:
726700
show subpopulations
Gnomad4 AFR exome
AF:
0.000299
AC:
10
AN:
33472
Gnomad4 AMR exome
AF:
0.00136
AC:
61
AN:
44722
Gnomad4 ASJ exome
AF:
0.00528
AC:
138
AN:
26126
Gnomad4 EAS exome
AF:
0.00
AC:
0
AN:
39692
Gnomad4 SAS exome
AF:
0.00652
AC:
562
AN:
86258
Gnomad4 FIN exome
AF:
0.000286
AC:
15
AN:
52452
Gnomad4 NFE exome
AF:
0.00257
AC:
2859
AN:
1111896
Gnomad4 Remaining exome
AF:
0.00263
AC:
159
AN:
60370
Heterozygous variant carriers
0
261
522
783
1044
1305
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Exome Het
Exome Hom
Variant carriers
0
112
224
336
448
560
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.00184
AC:
281
AN:
152334
Hom.:
1
Cov.:
34
AF XY:
0.00203
AC XY:
151
AN XY:
74506
show subpopulations
Gnomad4 AFR
AF:
0.000313
AC:
0.000312665
AN:
0.000312665
Gnomad4 AMR
AF:
0.00196
AC:
0.00196053
AN:
0.00196053
Gnomad4 ASJ
AF:
0.00461
AC:
0.00460829
AN:
0.00460829
Gnomad4 EAS
AF:
0.00
AC:
0
AN:
0
Gnomad4 SAS
AF:
0.00952
AC:
0.00951593
AN:
0.00951593
Gnomad4 FIN
AF:
0.0000941
AC:
0.0000941265
AN:
0.0000941265
Gnomad4 NFE
AF:
0.00246
AC:
0.00245502
AN:
0.00245502
Gnomad4 OTH
AF:
0.00379
AC:
0.00378788
AN:
0.00378788
Heterozygous variant carriers
0
14
27
41
54
68
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Genome Het
Variant carriers
0
10
20
30
40
50
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00238
Hom.:
0
Bravo
AF:
0.00163
Asia WGS
AF:
0.00260
AC:
9
AN:
3478
EpiCase
AF:
0.00273
EpiControl
AF:
0.00373

ClinVar

Significance: Benign/Likely benign
Submissions summary: Benign:8
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:6
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Jun 07, 2019
Athena Diagnostics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Apr 01, 2025
CeGaT Center for Human Genetics Tuebingen
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

BRAT1: BP4, BP7, BS2 -

Oct 08, 2020
GeneDx
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

-
Clinical Genetics DNA and cytogenetics Diagnostics Lab, Erasmus MC, Erasmus Medical Center
Significance:Likely benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

-
Genome Diagnostics Laboratory, University Medical Center Utrecht
Significance:Likely benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

BRAT1-related disorder Benign:1
Oct 24, 2019
PreventionGenetics, part of Exact Sciences
Significance:Likely benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). -

Neonatal-onset encephalopathy with rigidity and seizures Benign:1
Jan 30, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.80
CADD
Benign
0.18
DANN
Benign
0.51
Mutation Taster
=100/0
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs61753093; hg19: chr7-2577961; API